Self-Treatment for Obsessive Compulsive Disorder Using a Manual and a Computerized Telephone Interview: A U.S.-U.K. Study

M.D. Computing

Volumn 15, Issue 3, 1998, Pages 149-157

  Greist, John H ^a   Marks, Isaac M ^b   Baer, Lee ^b   Parkin, J Richard ^b   Manzo, Peter A ^b   Mantle, Julia M ^b   Wenzel, Keith W ^b   Spierings, Christopher J ^b   Kobak, Kenneth A ^b   Dottl, Susan L ^b   Bailey, Terese M ^b   Forman, Leslie ^b  

^a Dean Found Hlth   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED THERAPY; FEMALE; HUMAN; INTERVIEW; MALE; METHODOLOGY; MIDDLE AGED; OBSESSIVE COMPULSIVE DISORDER; PATIENT PARTICIPATION; PATIENT SATISFACTION; PILOT STUDY; REPRODUCIBILITY; SELF CARE; SELF EVALUATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADULT; BEHAVIOR THERAPY; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PATIENT PARTICIPATION; PATIENT SATISFACTION; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SELF CARE; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME; UNITED STATES;

EID: 0032062837     PISSN: 07246811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1994; 55: 5-10.
2. Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. Br J Psychiatry 1995; 166(suppl 27): 19-22.
3. Calvocoressi L, Lewis B, Harris M, et al. Family accommodation in obsessive-compulsive disorder. Am J Psychiatry 1995; 152: 441-3.
4. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive-compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-compulsive disorders: theory and management. Second edition. Chicago: Year Book Medical Publishers 1990, 10-27.
5. Jenike MA. Obsessive-compulsive and related disorders: a hidden epidemic. N Engl J Med 1989; 321: 539-41.
6. Goisman RM, Rogers MP, Steketee GS, Warshaw MG, Cuneo P, Keller MB. Utilization of behavioral methods in a multicenter anxiety disorders study. J Clin Psychiatry 1993; 54: 213-18.
7. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R. Clomipramine and exposure for obsessive-compulsive rituals: I. Br J Psychiatry 1980; 136: 1-25.
8. Van Balkom AJ, Van Oppen P, Vermeulen AWA, Van Dyck R, Nauta MCE, Vorst HCM. A meta-analysis on the treatment of obsessive-compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 1994; 14: 359-81.
9. Foa EB, Kozak MJ. Psychological treatment for obsessive-compulsive disorder. In: Mavissakalian MR, Prien RF, eds. Long-term treatments of anxiety disorders. Washington, DC: American Psychiatric Press, 1996, 285-309.
10. O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. J Clin Psychiatry 1991; 52: 150-5.
11. Turner SM, Beidel DC, Spaulding SA, Brown JM. The practice of behavior therapy: a national survey of costs and methods. Behavior Therapist 1995; 18: 1-4.
12. McDonald R, Marks IM, Blizard R. Quality assurance of outcome in mental health care: a model for routine use in clinical settings. Health Trends 1988; 20: 111-14.
13. Duggan C, Marks IM, Richards D. Clinical audit of behavior therapy training of nurses. Health Trends 1992; 25: 25-30.
14. McKenzie N, Blanes T, Marks IM. Computerised clinical benefit-cost audit of mental health care. II: Time input, costs, patient satisfaction. J Mental Health, 1995; 1: 71-8.
15. Marks IM, Lelliott P, Basoglu M, et al. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 1988; 152: 522-34.
16. Baer L. Computer-assisted behavior therapy for obsessive-compulsive disorder. Presented at the First International Obsessive Compulsive Disorder Conference, March 12-13, 1993, Capri, Italy. Weesp, Netherlands: Solvay Duphar, 1993: 152-3.
17. Goodman WP, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry 1989; 46: 1006-16.
18. Marks IM, Behavioural psychotherapy. Bristol: John Wright, 1986.
19. Bech P, Allerup P, Gram LF, et al. The Hamilton Depression Scale: evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981; 63: 290-9.
20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Third edition, revised. Washington, DC: American Psychiatric Association, 1987.
21. Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. New York: New York Psychiatric Institute, 1988.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23; 56-62.
23. Guy W. ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: U.S. Department of Health, Education, and Welfare (publication no. ADM 76-338), 1976.
24. DeVeaugh-Geiss J, Katz R, Landau P, et al. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1991; 48: 730-8.
25. Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994; 51: 559-67.
26. Greist JH, Jenike MA, Robinson D, et al. Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double blind, placebo-controlled trial. Eur J Clin Res 1995; 7: 195-204.
27. Greist JH, Chouinard G, Duboff E, et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52: 289-95.
28. Wheadon DE, Bushnell WD, Steiner M. A fixed dose comparison of 20, 40, or 60 mg paroxetine to placebo in the treatment of obsessive compulsive disorder. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Honolulu, December 13-17, 1993. Nashville, TN: Vanderbilt University, 1993.
29. Moore NC, Summer KR, Bloor RN. Do patients like psychometric testing by computer? J Clin Psychol 1984; 40: 875-7.
30. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152: 1368-71.
31. Greist JH, Gustafson DH, Strauss FF, Rowse GL, Laughren TP, Chiles JA. A computer interview for suicide-risk prediction. Am J Psychiatry 1973; 130: 1327-32.
32. Petrie K, Abell W. Responses of parasuicides to a computerized interview. Comput Hum Behav 1994; 10: 415-18.
33. Lucas RW, Mullin PJ, Luna CB, McInroy DC. Psychiatrists and a computer as interrogators of patients with alcohol-related illnesses: a comparison. Br J Psychiatry 1977; 131: 160-7.
34. Skinner HA, Allen BA. Does the computer make a difference? Computerized versus face-to-face versus self-report assessment of alcohol, drug, and tobacco use. J Counseling Clin Psychol 1983; 51: 267-75.
35. Erdman H, Klein MH, Greist JH. The reliability of a computer interview for drug use/abuse information. Behav Res Meth Instrumentation 1983; 15: 66-8.
36. Greist JH, Klein MH. Computer programs for patients, clinicians, and researchers in psychiatry. In: Sidowski JB, Johnson JH, Williams TA, eds. Technology in mental health care delivery systems. Norwood, NJ: Ablex, 1980, 16-182.
37. Kobak KA, Reynolds WM, Greist JH. Computerized and clinician assessment of depression and anxiety: respondent evaluation and satisfaction. J Personal Assess 1994; 63: 173-80.
38. Slack WV, Hicks P, Reed CE, Van Cura LJ. A computer-based medical history system. N Engl J Med 1966; 274: 194-8.
39. Lucey JV, Butcher G, Clare AW, Dinan TG. The clinical characteristics of patients with obsessive compulsive disorder: a descriptive study of an Irish sample. Irish J Psychol Med 1994; 11: 11-14.
40. Orloff LM, Battle MA, Baer L, et al. Long-term follow-up of 85 patients with obsessive-compulsive disorder. Am J Psychiatry 1994; 151: 441-2.